Jacobio Pharmaceuticals Group Co., Ltd. - Laporan Laba Rugi (TTM)

Jacobio Pharmaceuticals Group Co., Ltd.
US ˙ OTCPK ˙ KYG4987A1094

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Jacobio Pharmaceuticals Group Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 243 486 515 544 348 153 151 150 123 96 89 81 72 64 43 23 89 156 179 201
Change (%) 100.00 5.93 5.60 -35.95 -56.14 -0.98 -0.99 -18.04 -22.02 -7.49 -8.10 -10.98 -12.33 -31.75 -46.52 285.79 74.08 14.66 12.79
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 22 44 71 97 119 140 136 133 108 83 79 75 68 60 41 22 11
Change (%) 100.00 60.22 37.59 21.97 18.01 -2.60 -2.67 -18.68 -22.98 -4.77 -5.00 -9.89 -10.98 -31.44 -45.87 -50.00
% of Revenue 9.07 9.07 13.72 17.88 34.05 91.60 90.11 88.58 87.89 86.80 89.37 92.38 93.51 94.96 95.38 96.55 12.51
Gross Operating Profit 221 442 444 447 230 13 15 17 15 13 9 6 5 3 2 1 78 156 179 201
Change (%) 100.00 0.52 0.51 -48.56 -94.42 16.67 14.29 -13.07 -15.04 -25.45 -34.14 -24.18 -31.89 -37.50 -59.99 9,669.60 98.98 14.66 12.79
% of Revenue 90.93 90.93 86.28 82.12 65.95 8.40 9.89 11.42 12.11 13.20 10.63 7.62 6.49 5.04 4.62 3.45 87.49 100.00 100.00 100.00
SG&A 65 54 57 60 52 45 47 49 46 43 43 43 45 47 45 44 44 43 42 40
Change (%) -17.45 5.72 5.41 -12.85 -14.74 4.77 4.55 -6.43 -6.87 1.10 1.09 3.60 3.47 -2.71 -2.78 -1.18 -1.19 -3.06 -3.16
% of Revenue 26.82 11.07 11.05 11.03 15.01 29.17 30.87 32.59 37.21 44.44 48.57 53.43 62.18 73.39 104.61 190.17 48.71 27.65 23.37 20.07
R&D 171 186 211 237 259 281 308 336 391 446 457 468 420 372 361 350 340 330 288 247
Change (%) 8.80 13.62 11.99 9.35 8.55 9.78 8.91 16.36 14.06 2.49 2.43 -10.21 -11.37 -2.94 -3.03 -2.89 -2.97 -12.66 -14.50
% of Revenue 70.29 38.24 41.01 43.49 74.26 183.78 203.76 224.13 318.23 465.45 515.67 574.75 579.74 586.15 833.53 1,511.30 380.44 212.05 161.52 122.44
OpEx 249 276 330 383 414 445 473 501 539 577 586 596 536 475 440 404 381 359 318 278
Change (%) 10.77 19.36 16.22 8.11 7.50 6.28 5.91 7.55 7.02 1.70 1.67 -10.13 -11.27 -7.56 -8.18 -5.54 -5.86 -11.32 -12.77
% of Revenue 102.52 56.78 63.98 70.41 118.85 291.29 312.65 334.43 438.88 602.29 662.14 732.53 739.55 748.54 1,013.85 1,740.71 426.22 230.49 178.26 137.87
Operating Income -6 210 186 161 -66 -292 -322 -351 -416 -481 -498 -515 -463 -412 -396 -380 -292 -203 -140 -76
Change (%) -3,531.41 -11.70 -13.26 -140.80 345.12 10.07 9.15 18.47 15.59 3.53 3.41 -9.99 -11.10 -3.83 -3.98 -23.29 -30.37 -31.24 -45.42
% of Revenue -2.52 43.22 36.02 29.59 -18.85 -191.29 -212.65 -234.43 -338.88 -502.29 -562.14 -632.53 -639.55 -648.54 -913.85 -1,640.71 -326.22 -130.49 -78.26 -37.87
Interest Expense -1 -1 -1 -1 -1 -1 -0 -0 -1 -2 -4 -6 -7 -8 -9 -10 -9 -8 -10 -11
Change (%) -20.42 -21.22 -26.94 0.35 0.35 -15.58 -18.46 240.28 70.61 80.29 44.53 20.26 16.85 8.80 8.09 -7.04 -7.57 15.98 13.78
% of Revenue -0.51 -0.20 -0.15 -0.10 -0.16 -0.37 -0.32 -0.26 -1.08 -2.37 -4.62 -7.27 -9.82 -13.09 -20.86 -42.16 -10.16 -5.39 -5.46 -5.50
Net Income -1,298 -1,514 -1,177 -839 -570 -301 -297 -292 -332 -372 -391 -410 -385 -359 -361 -362 -259 -156 -101 -46
Change (%) 16.65 -22.27 -28.66 -32.06 -47.19 -1.46 -1.48 13.58 11.96 5.17 4.92 -6.24 -6.65 0.39 0.38 -28.49 -39.83 -35.34 -54.66
% of Revenue -533.69 -311.27 -228.39 -154.30 -163.69 -197.10 -196.16 -195.19 -270.52 -388.38 -441.56 -504.11 -530.96 -565.36 -831.57 -1,560.88 -289.33 -100.00 -56.39 -22.67

Source: Capital IQ

Other Listings
DE:77V
HK:1167 HK$ 11.41
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista